1. Home
  2. |Insights
  3. |DoJ “FOIA Post” Demonstrates Continued Policy To Disclose Unit Pricing

DoJ “FOIA Post” Demonstrates Continued Policy To Disclose Unit Pricing

Client Alert | less than 1 min read | 10.10.05

On September 8, 2005, the Department of Justice issued a “FOIA Post” memorandum (http://www.usdoj.gov/oip/foiapost/2005foiapost17.htm) reflecting on last year's decision by the D.C. Circuit in McDonnell Douglas Corp. v. U.S. Dep't of the Air Force, 375 F.3d 1182, in which the court rejected DOJ's efforts to have the contractor's unit prices released. The “FOIA Post” discusses various ways that agencies can distinguish that decision in favor of disclosure of unit-price information and advises agencies to look to Fourth and Ninth Circuit decisions which supported the disclosure of unit prices.

Contacts

Insights

Client Alert | 3 min read | 01.21.26

Atlantic Biologicals Opioid DPA: DOJ Continues Ramp Up of Criminal Corporate Healthcare Enforcement

On January 13, 2026, Miami-based pharmaceutical wholesaler Atlantic Biologicals Corporation entered into a two-year DPA, admitting to conspiracy to distribute and dispense controlled substances, including more than 14 million opioid doses to “pill mill” pharmacies in Texas at a markup. The DOJ and DEA underscored the company’s deliberate evasion of compliance checks and disregard for red flags signaling diversion....